enzastaurin has been researched along with vidarabine in 1 studies
| Studies (enzastaurin) | Trials (enzastaurin) | Recent Studies (post-2010) (enzastaurin) | Studies (vidarabine) | Trials (vidarabine) | Recent Studies (post-2010) (vidarabine) |
|---|---|---|---|---|---|
| 188 | 52 | 99 | 4,976 | 974 | 1,525 |
| Protein | Taxonomy | enzastaurin (IC50) | vidarabine (IC50) |
|---|---|---|---|
| Dipeptidyl peptidase 4 | Homo sapiens (human) | 0.062 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fournié, JJ; Laurent, G; Liffraud, C; Quillet-Mary, A; Ysebaert, L | 1 |
1 other study(ies) available for enzastaurin and vidarabine
| Article | Year |
|---|---|
Protein phosphatase-2A activation is a critical step for enzastaurin activity in chronic lymphoid leukemia cells.
Topics: Antineoplastic Agents; Cell Death; Drug Resistance, Neoplasm; Enzyme Activation; Humans; Indoles; Leukemia, Lymphocytic, Chronic, B-Cell; Phosphorylation; Protein Kinase Inhibitors; Protein Phosphatase 2; Tumor Cells, Cultured; Vidarabine | 2012 |